All In Biotech

Free tool

FAERS Monitor: Trimethoprim

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018679 or its brand name (Trimethoprim, Trimethoprim). Reports on generic versions are filed under their own applications.

Reports

11,863

Serious

10,877

92% of reports

Hospitalization

5,137

Death reported

1,558

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea977
  • off label use959
  • headache910
  • diarrhoea876
  • malaise870
  • drug ineffective801
  • dyspnoea763
  • pyrexia749
  • vomiting746
  • fatigue683
  • rash633
  • dizziness632
  • pain623
  • acute kidney injury615
  • arthralgia571

Reports by year received

View as table
YearReports
200499
2005126
2006139
2007172
2008161
2009209
2010238
2011344
2012430
2013443
2014603
2015677
2016722
2017541
2018848
2019931
2020877
2021852
2022842
2023782
2024756
2025625
2026445

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,296 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal6157.16.63,258
pyrexiaSignal7493.83.61,596
malaiseSignal8703.53.31,599
vomitingSignal7462.82.6890
rashSignal6332.62.4621
headacheSignal9102.62.4901
arthralgiaSignal5712.42.2491
diarrhoeaSignal8762.42.3742
dyspnoeaSignal7632.42.2633
dizzinessSignal6322.22.1447
nauseaSignal9772.22.1654
off label use9591.91.8456
pain6231.81.7227
fatigue6831.61.4140
drug ineffective8011.11.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.